Apr. 04 2024
Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use GuidelinesFound: (e.g., bilirubin) may gain access to the CNS with resultant toxicity.
Apr. 04 2024
Source Page: Government response to the Regulatory Horizons Council report on neurotechnologyFound: Government response to the Regulatory Horizons Council report on neurotechnology
Apr. 02 2024
Source Page: Prohibition of the sale and supply of single-use vapes - interim Partial Business and Regulatory Impact AssessmentFound: Prohibition of the sale and supply of single-use vapes - interim Partial Business and Regulatory Impact
Mar. 28 2024
Source Page: The future of futures: participatory futures research in the ASCFound: Long (+10 yrs)Short (0-5yrs)medium (5 - 10rs)Timescale:SummaryPre-Clinical Testing of Novel Medical Devices
Mar. 28 2024
Source Page: General Medical Services Statement of Financial Entitlements Directions: previous directionsFound: General Medical Services Statement of Financial Entitlements Directions: previous directions
Mar. 27 2024
Source Page: Make a claim through the risk protection arrangement (RPA)Found: vehicles xi) undertaking medical procedures and provision of prescribed medicines subject to adherence
Mar. 27 2024
Source Page: Make a claim through the risk protection arrangement (RPA)Found: vehicles xi) undertaking medical procedures and provision of prescribed medicines subject to adherence
Mar. 27 2024
Source Page: Make a claim through the risk protection arrangement (RPA)Found: xi) undertaking medical procedures and provision of prescribed medicines subject to adherence with
Mar. 27 2024
Source Page: Make a claim through the risk protection arrangement (RPA)Found: 14 xi) undertaking medical procedures and provision of prescribed medicines subject to adherence with
Mar. 27 2024
Source Page: Make a claim through the risk protection arrangement (RPA)Found: plant 16 xi) undertaking medical procedures and provision of prescribed medicines subject to adherence